Clinical research in smoking cessation has become an increasingly sophisticated enterprise. Although many of the design issues in smoking cessation research are similar to those encountered in other clinical areas, the types of outcomes measured and the structure of the outcome data have special features that set them apart. Standard methods of modeling and analysis that statisticians have developed over the years are therefore not well suited to handling data from smoking cessation trials. We propose to develop a range of statistical models and estimation procedures to handle the special features of smoking cessation outcomes. The availability of appropriate methods for this setting will further clinical research by permitting investigators to mine their data for new insights and design and analyze trials with maximum efficiency. This application describes a proposal by a team of experienced statisticians to address a range of critical methodologic problems arising in clinical trials of smoking cessation treatments.
The first aim will investigate the problem of estimating the rates of smoking cure, together with the effects of treatments on cure and relapse rates, from data on cigarette consumption when subjects may experience alternating periods of abstinence and relapse.
The second aim will consider models for daily cigarette consumption data in which the distribution of cigarette counts may exhibit excess zeros, a consequence of periods of abstinence; an integrated model based on smoking intensity rates will link models for abstinence and consumption given non-abstinence.
The third aim will address the issue of heaping of cigarette counts - i.e., the tendency of subjects to report cigarette consumption rounded to the nearest multiple of five, ten or twenty cigarettes. The methods will be applied to data from a number of smoking cessation trials conducted by the University of Pennsylvania's NIH-funded Transdisciplinary Tobacco Use Research Center and the University of Pittsburgh, in which the three investigators have been active collaborators. It is anticipated, however, that the resulting methods will be applicable more broadly to clinical research on outcomes that experience alternating periods of relapse and remission. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA116723-02
Application #
7409198
Study Section
Biostatistical Methods and Research Design Study Section (BMRD)
Program Officer
Feuer, Eric J
Project Start
2007-05-01
Project End
2010-04-30
Budget Start
2008-05-01
Budget End
2009-04-30
Support Year
2
Fiscal Year
2008
Total Cost
$235,558
Indirect Cost
Name
University of Pennsylvania
Department
Biostatistics & Other Math Sci
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Mokdad, Ali A; Xie, Xian-Jin; Zhu, Hong et al. (2018) Statistical justification of expansion cohorts in phase 1 cancer trials. Cancer 124:3339-3345
Wileyto, E Paul; Li, Yimei; Chen, Jinbo et al. (2013) Assessing the fit of parametric cure models. Biostatistics 14:340-50
Liu, Tao; Heitjan, Daniel F (2012) Sensitivity of the discrete-time Kaplan-Meier estimate to nonignorable censoring: Application in a clinical trial. Stat Med 31:2998-3010
Wang, Hao; Shiffman, Saul; Griffith, Sandra D et al. (2012) Truth and Memory: Linking Instantaneous and Retrospective Self-Reported Cigarette Consumption. Ann Appl Stat 6:1689-1706
Li, Yimei; Wileyto, E Paul; Heitjan, Daniel F (2011) Statistical analysis of daily smoking status in smoking cessation clinical trials. Addiction 106:2039-46
Li, Yimei; Wileyto, E Paul; Heitjan, Daniel F (2011) Prediction of individual long-term outcomes in smoking cessation trials using frailty models. Biometrics 67:1321-9
Li, Yimei; Wileyto, E Paul; Heitjan, Daniel F (2010) Modeling smoking cessation data with alternating states and a cure fraction using frailty models. Stat Med 29:627-38
Guo, Mengye; Heitjan, Daniel F (2010) Multiplicity-calibrated Bayesian hypothesis tests. Biostatistics 11:473-83
Griffith, Sandra D; Shiffman, Saul; Heitjan, Daniel F (2009) A method comparison study of timeline followback and ecological momentary assessment of daily cigarette consumption. Nicotine Tob Res 11:1368-73
Heitjan, Daniel F; Guo, Mengye; Ray, Riju et al. (2008) Identification of pharmacogenetic markers in smoking cessation therapy. Am J Med Genet B Neuropsychiatr Genet 147B:712-9

Showing the most recent 10 out of 11 publications